Decrease of Trefoil factor 2 in cats with feline idiopathic cystitis

BJU International

Volumn 107, Issue 4, 2011, Pages 670-677

  Lemberger, Stephanie I K ^a   Dorsch, Roswitha ^a   Hauck, Stefanie M ^a   Amann, Barbara ^a   Hirmer, Sieglinde ^a   Hartmann, Katrin ^a   Deeg, Cornelia A ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Feline idiopathic cystitis; impaired bladder defence; Interstitial cystitis; Trefoil factor 2; urinary biomarker

Indexed keywords

BIOLOGICAL MARKER; GROWTH FACTOR; TREFOIL FACTOR 2; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLADDER BIOPSY; CAT DISEASE; CONTROLLED STUDY; FELINE IDIOPATHIC CYSTITIS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; URINALYSIS; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CAT DISEASES; CATS; CYSTITIS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; PEPTIDES;

EID: 79551555028     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09500.x     Document Type: Article

References (34)

1. Gunn-Moore DA,. Feline lower urinary tract disease. J Feline Med Surg 2003; 5: 133-8
2. Cameron ME, Casey RA, Bradshaw JW, Waran NK, Gunn-Moore DA,. A study of environmental and behavioural factors that may be associated with feline idiopathic cystitis. J Small Anim Pract 2004; 45: 144-7
3. Lekcharoensuk C, Osborne CA, Lulich JP,. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc 2001; 218: 1429-35
4. Kruger JM, Osborne CA, Lulich JP,. Changing paradigms of feline idiopathic cystitis. Vet Clin North Am Small Anim Pract 2009; 39: 15-40
5. Lavelle JP, Meyers SA, Ruiz WG, Buffington CA, Zeidel ML, Apodaca G,. Urothelial pathophysiological changes in feline interstitial cystitis: a human model. Am J Physiol Renal Physiol 2000; 278: F540-53
6. Keay S, Zhang CO, Kagen DI, et al. Concentrations of specific epithelial growth factors in the urine of interstitial cystitis patients and controls. J Urol 1997; 158: 1983-8
7. Westropp JL, Buffington CA,. In vivo models of interstitial cystitis. J Urol 2002; 167: 694-702
8. Clasper M,. A case of interstitial cystitis and Hunner's ulcer in a domestic shorthaired cat. N Z Vet J 1990; 38: 158-60
9. Dell JR, Mokrzycki ML, Jayne CJ,. Differentiating interstitial cystitis from similar conditions commonly seen in gynecologic practice. Eur J Obstet Gynecol Reprod Biol 2009; 144: 105-9
10. Hanno P, Dmochowski R,. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 2009; 28: 274-86
11. Carr LK, Corcos J, Nickel JC, Teichman J,. Diagnosis of interstitial cystitis June 2007. Can Urol Assoc J 2009; 3: 81-6
12. Keay S, Zhang CO, Trifillis AL, et al. Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 1996; 156: 2073-8
13. Keay SK, Zhang CO, Shoenfelt J, et al. Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 2001; 57: 9-14
14. Hauck SM, Schoeffmann S, Deeg CA, Gloeckner CJ, Swiatek-de Lange M, Ueffing M,. Proteomic analysis of the porcine interphotoreceptor matrix. Proteomics 2005; 5: 3623-36
15. Hauck SM, Ekstrom PA, Ahuja-Jensen P, Suppmann S, Paquet-Durand F, van Veen T, et al. Differential modification of phosducin protein in degenerating rdl retina is associated with constitutively active Ca2+/calmodulin kinase II in rod outer segment. Mol Cell Proteomics 2006; 5: 324-36
16. Kim HJ, Park MH,. Obstructive uropathy due to interstitial cystitis in a patient with systemic lupus erythematosus. Clin Nephrol 1996; 45: 205-8
17. Cameron AP, Gajewski JB,. Bladder outlet obstruction in painful bladder syndrome/interstitial cystitis. Neurourol Urodyn 2009; 28: 944-8
18. Peters T Jr,. Serum albumin: recent progress in the understanding of its structure and biosynthesis. Clin Chem 1977; 23: 5-12
19. May FE, Semple JI, Newton JL, Westley BR,. The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach. Gut 2000; 46: 454-9
20. Dhar DK, Wang TC, Tabara H, et al. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis. Clin Cancer Res 2005; 11: 6472-8
21. Farrell JJ, Taupin D, Koh TJ, et al. TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002; 109: 193-204
22. Regalo G, Wright NA, Machado JC,. Trefoil factors: from ulceration to neoplasia. Cell Mol Life Sci 2005; 62: 2910-5
23. Chutipongtanate S, Nakagawa Y, Sritippayawan S, et al. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor. J Clin Invest 2005; 115: 3613-22
24. Alison MR, Chinery R, Poulsom R, Ashwood P, Longcroft JM, Wright NA,. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 1995; 175: 405-14
25. Kjellev S,. The trefoil factor family-small peptides with multiple functionalities. Cell Mol Life Sci 2009; 66: 1350-69
26. Taupin DR, Kinoshita K, Podolsky DK,. Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 2000; 97: 799-804
27. Baus-Loncar M, Kayademir T, Takaishi S, Wang T,. Trefoil factor family 2 deficiency and immune response. Cell Mol Life Sci 2005; 62: 2947-55
28. Baus-Loncar M, Schmid J, Lalani N, et al. Trefoil factor 2 (TFF2) deficiency in murine digestive tract influences the immune system. Cell Physiol Biochem 2005; 16: 31-42
29. Lanningham-Foster L, Green CL, Langkamp-Henken B, et al. Overexpression of CRIP in transgenic mice alters cytokine patterns and the immune response. Am J Physiol 2002; 282: E1197-203
30. Kurt-Jones EA, Cao L, Sandor F, et al. Trefoil family factor 2 is expressed in murine gastric and immune cells and controls both gastrointestinal inflammation and systemic immune responses. Infect Immun 2007; 75: 471-80
31. Michelis R, Sela S, Sbeit W, Cohen HI, Reshef R,. Decreased TFF2 expression in the gastric antrum in patients infected with CagA-positive Helicobacter pylori. Isr Med Assoc J 2009; 11: 11-5
32. Leung WK, Yu J, Chan FK, et al. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues. J Pathol 2002; 197: 582-8
33. Garraway IP, Seligson D, Said J, Horvath S, Reiter RE,. Trefoil factor 3 is overexpressed in human prostate cancer. Prostate 2004; 61: 209-14
34. Poulsen SS, Thulesen J, Christensen L, Nexo E, Thim L,. Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 1999; 45: 516-22